Molecular characterisation of breast cancer: the mutational landscape

New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer

Metabolism in malignant tumors: a new approach for treating breast cancer

Personalised medicine and nursing

Highlights of the first Cancer and Pregnancy Meeting

Impact of treatment on pregnancy

Effects of metformin in pancreatic cancer with diabetes

Targeting the cancer genome

Metformin to slow prostate cancer growth

Galeterone safe and effective against prostate cancer

Selumetinib controlled recurrent low-grade serous ovarian cancer

Ibrutinib induces responses in aggressive lymphomas